{'fraction_non_alphanumeric': 0.017543859649122806, 'fraction_numerical': 0.014844804318488529, 'mean_word_length': 5.625, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Response to neoadjuvant treatment in patients with breast cancer from the Department of Medical Oncology of the Hospital de Clínicas

introduction: Breast cancer is one of the most frequent malignant tumors in women; in Paraguay it has a high mortality. Neoadjuvant chemotherapy was introduced to reduce the size of the tumor and make resectables the tumors considered unresectables, allowing to perform conservative surgeries and test the sensitivity to chemotherapy. Material and methods: Descriptive study, transverse, retrospective and with analytical component. Sample: 130 patients with breast cancer who received neoadjuvant treatment in the Department of Medical Oncology of Hospital de Clínicas FCM-UNA from 2010 to 2016. Variables: